DAGCO Inc’s Medicus Pharma MDCX Stock Holding History

DAGCO Inc’s Portfolio MDCX Stock Details MDCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-349	Closed	-$534	–	391
2025 Q4	$534	Hold	349	–	–	﹤0.01%	380
2025 Q3	$808	Sell	349 -1	-0.3%	-$3	﹤0.01%	361
2025 Q2	$1.05K	Buy	+350	New	+$1.4K	﹤0.01%	356

Other funds holding MDCX

ICP

Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return

MHC

May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

DAGCO Inc's MDCX Position: Q1 2026 in Review

DAGCO Inc sold out of Medicus Pharma (MDCX) in Q1 2026, closing a stake of 349 shares — an estimated $534 sold.

DAGCO Inc first reported a position in MDCX in Q2 2025 and held it in 3 quarters. The position peaked at $1.05K in Q2 2025. 21 funds tracked by Wall St. Rank hold MDCX as of Q1 2026.

DAGCO Inc reported no remaining Medicus Pharma position as of Q1 2026 after selling out during the quarter.
DAGCO Inc sold 349 Medicus Pharma shares in Q1 2026, an estimated $534.
DAGCO Inc first reported a position in Medicus Pharma in Q2 2025 and held it in 3 quarters.
DAGCO Inc's Medicus Pharma position peaked at $1.05K in Q2 2025.
21 funds tracked by Wall St. Rank held Medicus Pharma as of Q1 2026.

Based on DAGCO Inc's 13F filing for Q1 2026, filed 20 Apr 2026.